Correlation Between Degree of Neointimal Hyperplasia and Incidence and Characteristics of Neoatherosclerosis as Assessed by Optical Coherence Tomography - 23/10/13

Abstract |
Emerging evidence suggests that neointimal degenerative changes with development of neoatherosclerosis (NA) may represent an important mechanism for late stent failure. The aim of the present study was to investigate the relation between degree of neointimal hyperplasia and incidence and characteristics of NA using optical coherence tomography. We identified a total of 252 stents with mean neointimal thickness (NIT) >100 μm in 212 patients: 100 bare metal stents (BMSs) and 152 drug-eluting stents (DESs). Based on the values of mean NIT, we divided stents into tertiles and compared neointimal characteristics among the 3 groups. NA was defined as the presence of lipid-laden intima and/or calcification inside the stent. In both BMS and DES, there was a difference in the prevalence of lipid-laden intima among the tertiles (18.2% vs 36.4% vs 47.1%, p = 0.042 [BMS]; 19.6% vs 56.9% vs 88.0%, p <0.001 [DES]). However, no difference in the prevalence of in-stent calcification was observed (21.2% vs 21.2% vs 2.9%, p = 0.053 [BMS]; 5.9% vs 9.8% vs 2.0%, p = 0.252 [DES]). In a multivariate model adjusting for stent type, follow-up duration, conventional coronary risk factors, statin, and angiotensin-converting enzyme inhibitor or angiotensin II receptor blockade use, mean NIT was independently associated with the presence of NA (odds ratio 2.53, 95% confidence interval 1.96 to 3.27, p <0.001). This study demonstrates the presence of a positive correlation between degree of neointimal hyperplasia after stent implantation and presence of lipid-laden intima. This association is independent from stent type and time from implantation and suggests a possible pathogenic link between the two processes.
Le texte complet de cet article est disponible en PDF.Plan
| Dr. Jang has received grant support and consulting fees from the LightLab Imaging Inc., St. Jude Medical Inc. Dr. Vergallo is supported by the “Enrico ed Enrica Sovena” Foundation, Rome, Italy. Dr. Kato is supported by the Japan Heart Foundation and Bayer Yakuhin Research Grant Abroad and the Mitsukoshi Health and Welfare Foundation. Dr. Jia is supported by the National Natural Science Foundation of China (contract number: 81200076). Dr. Yu has received a grant from the National Natural Science Foundation of China (contract number: 30871064/C140401). Dr. Zhang is an employee of LightLab Imaging Inc., St. Jude Medical Inc. This study was supported by the Dr. John Nam Research Fellowship grant. |
|
| See page 1321 for disclosure information. |
Vol 112 - N° 9
P. 1315-1321 - novembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
